Literature DB >> 20506565

Sex differences in the relationship of regional dopamine release to affect and cognitive function in striatal and extrastriatal regions using positron emission tomography and [¹⁸F]fallypride.

Patrizia Riccardi1, Sohee Park, Sharlet Anderson, Mikisha Doop, M Sib Ansari, Dennis Schmidt, Ronald Baldwin.   

Abstract

The purpose of this study was to examine sex differences in the correlations of d-amphetamine (d-AMPH) induced displacements of [¹⁸F]fallypride in striatal and extrastriatal regions in relation to affect and cognition. Seven male and six female healthy subjects, whose mean age was 25.9 years, underwent positron emission tomography (PET) with [¹⁸F]fallypride at baseline and 3 h after a 0.43 mg/kg oral dose of d-AMPH. Percent displacements in striatal and extrastriatal regions were calculated using regions of interest (ROI) analysis and on a pixel-by-pixel basis. Subjects underwent neuropsychological testing prior to the baseline PET study and one hour after d-AMPH administration for the second PET. In order to examine the subjective effect of d-AMPH, subjects rated PANAS at baseline and after administration of amphetamine. Correlations of changes in cognition and affect with regional dopamine (DA) release revealed several significant sex related differences. The results of this study demonstrate in vivo sex related differences in the relationship of regional DA release to affect and cognitive function.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20506565      PMCID: PMC2965297          DOI: 10.1002/syn.20822

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  22 in total

Review 1.  Drug addiction, dysregulation of reward, and allostasis.

Authors:  G F Koob; M Le Moal
Journal:  Neuropsychopharmacology       Date:  2001-02       Impact factor: 7.853

Review 2.  Gender differences in dopaminergic function in striatum and nucleus accumbens.

Authors:  J B Becker
Journal:  Pharmacol Biochem Behav       Date:  1999-12       Impact factor: 3.533

Review 3.  Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions.

Authors:  Amy F T Arnsten; Bao-Ming Li
Journal:  Biol Psychiatry       Date:  2005-06-01       Impact factor: 13.382

4.  The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability.

Authors:  J B Williams; M Gibbon; M B First; R L Spitzer; M Davies; J Borus; M J Howes; J Kane; H G Pope; B Rounsaville
Journal:  Arch Gen Psychiatry       Date:  1992-08

Review 5.  Prefrontal neurons and the genetics of schizophrenia.

Authors:  D R Weinberger; M F Egan; A Bertolino; J H Callicott; V S Mattay; B K Lipska; K F Berman; T E Goldberg
Journal:  Biol Psychiatry       Date:  2001-12-01       Impact factor: 13.382

6.  Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans.

Authors:  Patrizia Riccardi; Rui Li; Mohammad Sib Ansari; David Zald; Sohee Park; Benoit Dawant; Sharlet Anderson; Mikisha Doop; Neil Woodward; Evan Schoenberg; Dennis Schmidt; Ronald Baldwin; Robert Kessler
Journal:  Neuropsychopharmacology       Date:  2006-05       Impact factor: 7.853

7.  Sex differences in the effect of amphetamine on immediate early gene expression in the rat dorsal striatum.

Authors:  S A Castner; J B Becker
Journal:  Brain Res       Date:  1996-03-18       Impact factor: 3.252

Review 8.  Modulation of brain dopamine transmission by sex steroids.

Authors:  T Di Paolo
Journal:  Rev Neurosci       Date:  1994 Jan-Mar       Impact factor: 4.353

Review 9.  Dopamine: a key regulator to adapt action, emotion, motivation and cognition.

Authors:  André Nieoullon; Antoine Coquerel
Journal:  Curr Opin Neurol       Date:  2003-12       Impact factor: 5.710

10.  Direct effect of 17 beta-estradiol on striatum: sex differences in dopamine release.

Authors:  J B Becker
Journal:  Synapse       Date:  1990       Impact factor: 2.562

View more
  24 in total

Review 1.  Emergence of sex differences in the development of substance use and abuse during adolescence.

Authors:  Cynthia Kuhn
Journal:  Pharmacol Ther       Date:  2015-06-03       Impact factor: 12.310

2.  The relationship between subcortical brain volume and striatal dopamine D2/3 receptor availability in healthy humans assessed with [11 C]-raclopride and [11 C]-(+)-PHNO PET.

Authors:  Fernando Caravaggio; Jun Ku Chung; Eric Plitman; Isabelle Boileau; Philip Gerretsen; Julia Kim; Yusuke Iwata; Raihaan Patel; M Mallar Chakravarty; Gary Remington; Ariel Graff-Guerrero
Journal:  Hum Brain Mapp       Date:  2017-07-28       Impact factor: 5.038

Review 3.  The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities.

Authors:  Stephen V Faraone
Journal:  Neurosci Biobehav Rev       Date:  2018-02-08       Impact factor: 8.989

Review 4.  Sex differences in fear extinction.

Authors:  E R Velasco; A Florido; M R Milad; R Andero
Journal:  Neurosci Biobehav Rev       Date:  2019-05-23       Impact factor: 8.989

5.  Sex differences in response to amphetamine in adult Long-Evans rats performing a delay-discounting task.

Authors:  Paul A Eubig; Terese E Noe; Stan B Floresco; Jeffrey J Sable; Susan L Schantz
Journal:  Pharmacol Biochem Behav       Date:  2013-12-31       Impact factor: 3.533

6.  Variability in paralimbic dopamine signaling correlates with subjective responses to d-amphetamine.

Authors:  Christopher T Smith; Linh C Dang; Ronald L Cowan; Robert M Kessler; David H Zald
Journal:  Neuropharmacology       Date:  2016-05-10       Impact factor: 5.250

7.  Amphetamine effects on MATRICS Consensus Cognitive Battery performance in healthy adults.

Authors:  Hsun-Hua Chou; Jo A Talledo; Sarah N Lamb; Wesley K Thompson; Neal R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2013-01-12       Impact factor: 4.530

8.  Establishing test-retest reliability of an adapted [(18)F]fallypride imaging protocol in older people.

Authors:  Joel T Dunn; Chloe Clark-Papasavas; Paul Marsden; Stacey Baker; Marcel Cleij; Shitij Kapur; Robert Kessler; Robert Howard; Suzanne J Reeves
Journal:  J Cereb Blood Flow Metab       Date:  2013-04-17       Impact factor: 6.200

9.  Family history of alcoholism is related to increased D2 /D3 receptor binding potential: a marker of resilience or risk?

Authors:  Anika A H Alvanzo; Gary S Wand; Hiroto Kuwabara; Dean F Wong; Xiaoqiang Xu; Mary E McCaul
Journal:  Addict Biol       Date:  2015-09-29       Impact factor: 4.280

10.  Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence.

Authors:  Theresa M Winhusen; Frankie Kropp; Robert Lindblad; Antoine Douaihy; Louise Haynes; Candace Hodgkins; Karen Chartier; Kyle M Kampman; Gaurav Sharma; Daniel F Lewis; Paul VanVeldhuisen; Jeff Theobald; Jeanine May; Gregory S Brigham
Journal:  J Clin Psychiatry       Date:  2014-07       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.